China, Oct. 19 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'T Cell Function Reboot Strategy for Anti-Tumor Research'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134595
Registration Time: 2026/10/16
Type: Observational study
Primary Sponsor: Guangxi Medical University Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=320729
Published by HT Digital Content Services with permission from Health Daily Digest....